Top Sell
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.26 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.56 | €3.00 | 434.569% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.03 | €3.65 | 253.627% |
| scPharmaceuticals | 3 | 1 | 0 | 0 | €4.28 | €16.43 | 283.888% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| ViewRay Inc | 0 | 3 | 0 | 0 | €0.025 | - | - |
| Novan Inc | 0 | 24 | 0 | 0 | €0.001 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.75 | €30.00 | 990.909% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.997% |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.86 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.24 | €7.00 | 212.500% |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.09 | €3.00 | 43.678% |
| Trevena Inc. | 1 | 14 | 0 | 1 | €0.36 | €8.37 | 2220.777% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.36 | €0.000 | -100.000% |
| T2 Biosystems Inc. | 0 | 12 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.40 | - | - |
| Medigene AG | 0 | 2 | 0 | 0 | €1.54 | €1.00 | -35.065% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 0 | €0.51 | €2.79 | 448.469% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 1 | €1.07 | €2.00 | 86.306% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.96 | - | - |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Pacific Biosciences of California Inc. | 10 | 5 | 0 | 0 | €1.73 | €10.20 | 488.574% |